J&J, Pfizer and Merck top Fortune’s 500 for the pharma industry, but large drug wholesalers and pharmacy benefit managers beat them easily. In 2017’s Fortune […]
Vice President Joe Biden and Dr. Jill Biden launched the Biden Cancer Initiative, their new venture to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce disparities […]
Biosimilar makers could get drugs to market more quickly following a recent ruling from the Supreme Court. In a unanimous opinion, the Supreme Court ruled that biosimilar drug developers […]
According to the 2017 Life Sciences Ideal Employer Report, the top three most important attributes are the opportunity to do interesting and meaningful work, a competitive […]
J&J, Pfizer and Merck top Fortune’s 500 for the pharma industry, but large drug wholesalers & pharmacy benefit managers beat them easily. In 2017’s Fortune […]
The FDA has approved a new allergic reaction medication that could provide an alternative to Mylan’s EpiPen. Adamis Pharmaceuticals’ Symjepi comes as two pre-filled syringes of […]
The battle over intellectual property rights to CRISPR-Cas9 continues between the University of California (UC) and the Broad Institute. In February, the U.S. Patent and Trademark […]